Wang Y, Xu J, Ma L, Hu H, Chen H, Hua J
BMJ Open. 2024; 14(7):e083730.
PMID: 39009458
PMC: 11253731.
DOI: 10.1136/bmjopen-2023-083730.
Di Gioia G, Buzzelli L, Maestrini V, Nenna A, Monosilio S, Squeo M
J Clin Med. 2023; 12(23).
PMID: 38068500
PMC: 10707559.
DOI: 10.3390/jcm12237449.
Mamillapalli R, Toffoloni N, Habata S, Qunhua H, Atwani R, Stachenfeld N
Am J Obstet Gynecol. 2022; 227(2):248.e1-248.e8.
PMID: 35351413
PMC: 9308711.
DOI: 10.1016/j.ajog.2022.03.040.
Golforoush P, Yellon D, Davidson S
Basic Res Cardiol. 2020; 115(6):73.
PMID: 33258000
PMC: 7704510.
DOI: 10.1007/s00395-020-00829-5.
Schneider D, Choi S, Agatisa-Boyle C, Zhu L, Kim J, Pattison J
J Lipid Res. 2018; 59(5):854-863.
PMID: 29559522
PMC: 5928435.
DOI: 10.1194/jlr.M083618.
Animal models of atherosclerosis.
Lee Y, Laxton V, Lin H, Fiona Chan Y, Fitzgerald-Smith S, To T
Biomed Rep. 2017; 6(3):259-266.
PMID: 28451383
PMC: 5403338.
DOI: 10.3892/br.2017.843.
Mouse models of atherosclerosis: a historical perspective and recent advances.
Lee Y, Lin H, Fiona Chan Y, Li K, To O, Yan B
Lipids Health Dis. 2017; 16(1):12.
PMID: 28095860
PMC: 5240327.
DOI: 10.1186/s12944-016-0402-5.
miRNA regulation of LDL-cholesterol metabolism.
Goedeke L, Wagschal A, Fernandez-Hernando C, Naar A
Biochim Biophys Acta. 2016; 1861(12 Pt B):2047-2052.
PMID: 26968099
PMC: 5375104.
DOI: 10.1016/j.bbalip.2016.03.007.
Novel method for reducing plasma cholesterol: a ligand replacement therapy.
Anantharamaiah G, Goldberg D
Clin Lipidol. 2015; 10(1):83-90.
PMID: 25937835
PMC: 4415983.
DOI: 10.2217/clp.14.63.
Arsonists and firefighters: the perpetual inflammatory civil war for survival.
Karliner J
Circulation. 2014; 129(23):2368-70.
PMID: 24710031
PMC: 4061904.
DOI: 10.1161/CIRCULATIONAHA.114.010006.
Making things stick in the fight against atherosclerosis.
Tabas I
Circ Res. 2013; 112(8):1094-6.
PMID: 23580771
PMC: 3662540.
DOI: 10.1161/CIRCRESAHA.113.301227.
The rationale for initiating treatment of hypercholesterolemia in young adulthood.
Steinberg D
Curr Atheroscler Rep. 2012; 15(1):296.
PMID: 23232986
DOI: 10.1007/s11883-012-0296-2.
New lipid and lipoprotein targets for the treatment of cardiometabolic diseases.
Hazen S
J Lipid Res. 2012; 53(9):1719-21.
PMID: 22766886
PMC: 3413215.
DOI: 10.1194/jlr.E030205.
Quercetin enhances ABCA1 expression and cholesterol efflux through a p38-dependent pathway in macrophages.
Chang Y, Lee T, Chiang A
J Lipid Res. 2012; 53(9):1840-50.
PMID: 22711909
PMC: 3413225.
DOI: 10.1194/jlr.M024471.
Primary prevention of coronary heart disease: integration of new data, evolving views, revised goals, and role of rosuvastatin in management. A comprehensive survey.
Kones R
Drug Des Devel Ther. 2011; 5:325-80.
PMID: 21792295
PMC: 3140289.
DOI: 10.2147/DDDT.S14934.
Pulling down the plug on atherosclerosis: finding the culprit in your heart.
Tabas I
Nat Med. 2011; 17(7):791-3.
PMID: 21738159
PMC: 3254051.
DOI: 10.1038/nm0711-791.
Macrophages in the pathogenesis of atherosclerosis.
Moore K, Tabas I
Cell. 2011; 145(3):341-55.
PMID: 21529710
PMC: 3111065.
DOI: 10.1016/j.cell.2011.04.005.
Dietary cholesterol and egg yolks: not for patients at risk of vascular disease.
Spence J, Jenkins D, Davignon J
Can J Cardiol. 2010; 26(9):e336-9.
PMID: 21076725
PMC: 2989358.
DOI: 10.1016/s0828-282x(10)70456-6.
Polysaccharide from fuzi (FPS) prevents hypercholesterolemia in rats.
Huang X, Tang J, Zhou Q, Lu H, Wu Y, Wu W
Lipids Health Dis. 2010; 9:9.
PMID: 20109183
PMC: 2835708.
DOI: 10.1186/1476-511X-9-9.
Indices of cholesterol metabolism and relative responsiveness to ezetimibe and simvastatin.
Lakoski S, Xu F, Vega G, Grundy S, Chandalia M, Lam C
J Clin Endocrinol Metab. 2009; 95(2):800-9.
PMID: 19965915
PMC: 3079219.
DOI: 10.1210/jc.2009-1952.